Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy by Zabirnyk, Olga et al.
Carcinogenesis vol.31 no.3 pp.446–454, 2010
doi:10.1093/carcin/bgp299
Advance Access publication November 25, 2009
Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent
autophagy
Olga Zabirnyk , Wei Liu, Shadi Khalil, Anit Sharma and
James M.Phang 
Metabolism and Cancer Susceptibility Section, Laboratory of Comparative
Carcinogenesis, Center for Cancer Research, National Cancer Institute,
Frederick, MD 21702-1201, USA
 To whom correspondence should be addressed. National Cancer Institute-
Frederick, National Institutes of Health, Building 538, Room 144, Frederick,
MD 21702, USA. Tel: þ1 301 846 5367; Fax: þ1 301 846 6093;
Email: olga_zabirnyk@yahoo.com
Correspondence may also be addressed to James M.Phang.
Tel: þ1 301 846 5367; Fax: þ1 301 846 6093;
Email: phangj@mail.nih.gov
Epidemiological studies showed that high levels of oxidized low-
density lipoproteins (oxLDLs) are associated with increased cancer
risk. We examined the direct effect of physiologic concentrations
oxLDL on cancer cells. OxLDLs were cytotoxic and activate both
apoptosis and autophagy. OxLDLs have ligands for peroxisome
proliferator-activated receptor gamma and upregulated proline
oxidase (POX) through this nuclear receptor. We identiﬁed 7-
ketocholesterol (7KC) as a main component responsible for the
latter. To elucidate the role of POX in oxLDL-mediated cytotoxicity,
we knocked down POX via small interfering RNA and found that
this (i) further reduced viability of cancer cells treated with oxLDL;
(ii)decreased oxLDL-associatedreactive oxygenspecies generation;
(iii) decreased autophagy measured via beclin-1 protein level
and light-chain 3 protein (LC3)-I into LC3-II conversion. Using
POX-expressing cell model, we established that single POX over-
expression was sufﬁcient to activate autophagy. Thus, it led to
autophagosomes accumulation and increased conversion of LC3-I
into LC3-II. Moreover, beclin-1 gene expression was directly
dependent on POX catalytic activity, namely the generation of
POX-dependent superoxide. We conclude that POX is critical in
the cellular response to the noxious effects of oxLDL by activating
protective autophagy.
Introduction
The epidemiologic association of obesity with increased cancer
risk has been reported (1), but the underlying mechanism for this
association remainsobscure.Inthecase of breastcancertheincrease
of adipose tissue mass and cumulative aromatase activity can affect
the metabolism of estrogens, a critical factor in breast carcinogen-
esis. However, for gastrointestinal as well as for other cancers, no
plausible mechanism has been elucidated. Some investigators have
pointed out the parallels between atherosclerosis and cancer in their
metabolic derangements (2). Obese subjects have not only increased
levels of cholesterol/low-density lipoprotein (LDL) and triglycer-
ides but also, more importantly, increased oxidative stress (3) lead-
ing to LDL conversion into oxidized low-density lipoprotein
(oxLDL) (4). This process of LDL oxidation plays a key role in
the development of atherosclerosis in both obese and lean patients.
It is important to emphasize the positive correlation between in-
creased serum oxLDL level and an increased risk of colon, breast
and ovarian cancer (5).
Pathophysiologic effects of oxLDL in atherosclerosis are ﬁrmly es-
tablished. The lowering of plasma oxLDL results in a marked retarda-
tion of atherosclerotic progression (6). However, atherosclerosis has
been an insufﬁcient model for carcinogenesis. In spite of accumulating
‘procarcinogenic’ epidemiologic data, there are no studies on the direct
effect of oxLDL on cancer development. On the one hand, components
of oxLDLstimulate cellproliferation (7,8) and mutagenesis invitro (9).
In contrast, it can also arrest cell growth (10), activate p53-dependent
apoptosis (11,12) and initiate autophagy (13,14). Clearly, additional
work is needed to elucidate context-dependent metabolic signaling re-
sponsible for the effects of oxLDL on carcinogenic processes.
We considered proline oxidase (POX) an ideal candidate to execute
oxLDL-dependent signaling. POX is a mitochondrial enzyme that
oxidizes proline, an unique imino acid, which may be derived from
microenvironmental sources under conditions of metabolic stress (15).
OxLDLs are a source of endogenous ligands for peroxisome
proliferator-activatedreceptorgamma(PPARc) (16)and POXresponds
to PPARc (17). More importantly, POX is a downstream target of p53
and generates proline-dependent reactive oxygen species (ROS) (18) to
induce apoptosis. Overexpression of POX initiates apoptosis in p53-
deﬁcient cells (19–21). The expression of POX is decreased in renal
carcinomas (19) and also in carcinomas of the digestive tract (22). On
the other hand, POX responds to nutrient stress in an mammalian target
of rapamycin (mTOR)-dependent process and increases the generation
of adenosine triphosphate (ATP) (23). This last fact links POX to au-
tophagy, a process regulated mainly through the mTOR pathway.
Macroautophagy, which we refer to here as autophagy, is a process of
‘self-eating’ (24), which serves a housekeeping role and degrades dam-
aged or unwanted organelles (25). Autophagy also serves to derive
energy during stress conditions (26). Beyond a threshold, this process
may eventually lead to cell death (27). Therefore, increased but not
excessive autophagy canbeneﬁt cancer cells and promotes their survival.
In this study we show for the ﬁrst time that oxLDLs have cytotoxic
effects on cancer cells invitro and activate both apoptosis and autoph-
agy. POX is upregulated by oxLDL through PPARc and plays a key
role in the regulation of protective autophagy in cancer cells. We
propose that POX-dependent autophagy is activated as a prosurvival
response to the noxious stimuli of oxLDL. The mechanism we de-
scribe may allow selection and survival of cancer cells.
Materials and methods
Cell culture
Human cancer cells HT29, HeLa, OVCAR3, OVCAR5, MCF7, A549 and PC3
were supplied by the National Cancer Institute repository and cultured in Dul-
becco’s modiﬁed Eagle’s medium (Quality Biologicals, Gaithersburg, MD) sup-
plementedwith10%fetal bovineserum(HyClone Laboratories,Logan,UT)and
2m ML-glutamine at37C and 5% CO2. Human umbilicalvein endothelial cells
(HUVECs) were purchased from PromoCell (Heidelberg, Germany) and cul-
tured in Endothelial Cell Growth Medium MV 2 supplemented with 10% fetal
bovine serum(HyCloneLaboratories)at37Ca n d5 %C O 2.DL D- 1T et -o f fPO X
cells, stably overexpressingPOX under the doxycycline depletion,werecultured
as described (18). All cell lines tested negative for mycoplasma contamination.
Abbreviations: ATP, adenosine triphosphate; HUVEC, human umbilical vein
endothelial cell; 7KC, 7-ketocholesterol; LC3, light-chain 3 protein; LDL,
low-density lipoprotein; mRNA, messenger RNA; mTOR, mammalian target
of rapamycin; nLDL, non-oxidized low-density lipoprotein; oxLDL, oxidized
low-density lipoprotein; PCR, polymerase chain reaction; POX, proline oxi-
dase; PPARc, peroxisome proliferator-activated receptor gamma; ROS, reac-
tive oxygen species; RT, reverse transcription.
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OxLDL and non-oxidized low-density lipoprotein (nLDL) were purchased
from Intracel (Frederick, MD). The level of oxidation was assessed using
a thiobarbituric acid reactive substances assay kit (Cayman, Ann Arbor, MI)
and estimated as 59.5 ± 0.5 nmol malondialdehyde per mg ApoB protein for
oxLDL and non-detectable for nLDL.
Cells were treated with oxLDL at physiological ranges (28,29). NLDL and un-
treated samples have been used as controls. Since Intracel supplied lipoproteins in
the NaCl/ethylenediaminetetraacetic acid, pH 7.2, we tested this buffer and it had
no effect on the POX promoter activity. Residual amounts of copper in the lip-
oproteins were determined with atomic absorption spectrophotometry, and addi-
tionof this amount of single copper sulfate had no effect onPOX promoter activity.
POX promoter activity
Before the assay, the cells were cotransfested with the POX-luciferase (PxP)
and pRL-null renilla construct (17). The cells were treated with various con-
centrations of oxLDL and nLDL at 6–10 h post-transfection. POX promoter
activitywas assessedwith Dual-Luciferase reporterAssay (Promega,Madison,
WI) in accordance with the manufacturer’s instruction. All experiments were
done in triplicates.
Western immunoblotting
The technique was done as described previously (17). Each experiment
has been done at least twice and representative scan is shown. Cytochrome
c-treated Jurkat cell extracts were used as positive controls for cleaved PARP
(Cell Signaling, Danvers, MA). Light-chain 3 protein (LC3)-positive controls
were from MBL (Woburn, MA).
POX enzyme activity
POX enzymatic activity was measured using O-aminobenzaldehyde assay
(17). Brieﬂy, pyrroline-5-carboxilate, the product of proline degradation, was
bound with the O-aminobenzaldehyde and then amount of this complex
was detected spectrophotometrically. The amount of pyrroline-5-carboxilate
was determined using a pyrroline-5-carboxilate standard curve and calculated
as nanomolar per minute per microgram of protein.
Reverse transcription–polymerase chain reaction
Total RNA was isolated using RNeasy Kit (Qiagen, Valencia, CA). The two-
step reverse transcription (RT)–polymerase chain reaction (PCR) was per-
formed with RT–PCR beads (GE Healthcare, Piscataway, NJ). The speciﬁc
primers for the POX were as follows: forward, 5#-GCCATTAAGCTCACAG-
CACTGGG-3#; reverse, 5#-CTGATGGCCGGCTGGAAGTAG-3# with a re-
sulting product of 300 bp. b-Actin was ampliﬁed as a loading control with
primers: forward, 5#-GATTCCTATGTGGGCGACGA-3#; reverse, 5#-CCAT-
CTCTTGCTCGAAGTCC-3# with a resulting product of 500 bp. PPARc was
ampliﬁed as recommended using RT–PCR primer from Santa Cruz Biotech-
nology (Santa Cruz, CA), PPARc (h)-PR with a resulting product of 596 bp.
Quantitative PCR
Total RNAwas extracted as described for RT–PCR and complementary DNA
was synthesized using SuperScriptTM III First-Strand Synthesis SuperMix
(Invitrogen, Carlsbad, CA).
Expression of the gene of interest was measured by TaqMan quantitative PCR
(Chromo4 Real-Time PCR detector; Bio-Rad, Hercules, CA). Inventoried Taq-
man primers for genes of interest and b-actin labeled with FAM and VIC ﬂuo-
rescent dyes, respectively, werefrom (Applied Biosystems, Foster City, CA).The
samples were run in triplicates for target and endogenous b-actin control. The
resultswereanalyzedusingMJOpticonMonitoranalysissoftware3.1(Bio-Rad).
Knockdown experiments
For POX knockdown, we used Stealth Select RNA interference (Invitrogen;
target accessions no. NM 016335). Stealth RNA interference negative control
Duplex (Invitrogen) was used as a control. Transfection efﬁciency was mon-
itored using a ﬂuorescent oligonucleotide (BLOCK-iT ﬂuorescent oligonucle-
otide; Invitrogen) and estimated as 80–90%. PPARc expression was knocked
down with small interfering RNA (Santa Cruz Biotechnology) according to the
manufacturer’s instructions. Knockdown efﬁciency was analyzed by RT–PCR
as described above for both POX Stealth RNA interference and PPARc small
interfering RNA (data not shown). Both transfections were done using Lip-
ofectamine2000 (Invitrogen).
Plasmids and viral vectors
MCherry-LC3 construct, cloned from the original enhanced green ﬂuorescent
protein-LC3 (Addgene plasmid 11546; Addgene, Cambridge, MA) was used
for autophagosomes visualization. We replaced green ﬂuorescent protein se-
quence by mCherry sequence to be able to use this vector in DLD Tet-off POX
cells, which already express green ﬂuorescent protein under the conditions of
doxycycline removal to report efﬁcient POX gene expression. Recombinant
adenoviral green ﬂuorescent protein construct (Ad-GFP), manganese superox-
idedismutase construct (Ad-MnSOD) andempty vector(Ad-Empty) were from
Gene Therapy Vector Core Facility ofthe University of Iowa.The infectionwas
done as described previously using 1000 multiplicity of infection (20).
Proliferation and viability assay
The effect of lipoproteins on cell viability/proliferation was estimated with
CellTiter 96Aqueous Solution Cell proliferation Assay (Promega).
ROS measurement
To measure intracellular ROS 2,7-dichlorohydroﬂuorescein diacetate (Sigma,
St Louis, MO) was used. Cells werewashed and exposed to serum-free, phenol
red-free medium containing 50 lM 2,7-dichlorohydroﬂuorescein diacetate for
1 h in the darkness and the ﬂuorescent intensity was measured using a spectro-
ﬂuorometer (Jovin Yvon Specs2) with excitation and emission wavelengths of
485 and 530 nm, respectively.
Microscopy and visualization
Morphological changesin cancer cells treatedwith lipoproteins were estimated
using an Axiovert 200M Zeiss microscope. Autophagosomes formation was
visualizedusing LSM 510 laser scanningmicroscope (Zeiss,Thornwood, NY).
Data analysis
The results are reported as a mean ± SD from at least three experiments.
Statistical differences between two groups were calculated by the unpaired
Student’s t-test,  P   0.05,   P   0.01.
Results
OxLDLs have cytotoxic effects on cancer cells in vitro and activate
apoptosis and autophagy
The effects of oxLDL were examined in several cancer cell lines:
HT29 (colon), OVCAR3 and OVCAR5 (ovarian), HeLa (cervical),
MCF7 (breast), A549 (lung) and PC3 (prostate). OxLDL, applied at
physiologic concentrations, decreased cell viability and proliferation
in a dose-dependent manner in all cell lines tested (Figure 1A),
whereas native nLDL had no effect (Figure 1B).
We also investigated the morphology of the cells treated with lip-
oproteins. NLDL (Figure 1C) and untreated control (data not shown)
did not have any microscopically discernible adverse effects on HT29
cells. In contrast, oxLDL decreased the cell number per ﬁeld and
caused the cells to round up (Figure 1C, white arrow). Numerous
non-adherent cells were observed and many neighboring cells lost
their cell–cell contacts (data not shown).
To elucidate the process underlying the decrease in cell viability,
we monitored apoptotic markers. First, in HT29 cells, the native 116
kDa PARP was cleaved to 85 kDa in a process dependent on duration
of exposure to 200 lg/ml of oxLDL (Figure 1D). Since autophagy is
often activated as a prosurvival mechanism during metabolic stress
and, if excessive, may lead to programmed cell death type II, we
also assessed markers of the autophagic process. The processing of
microtubule-associated LC3 from the 18 kDa cytosolic LC3-I into
the 16 kDa autophagosome-bound LC3-II lipidated form is a reliable
marker of autophagy (30). We found a time-dependent increase of
LC3-II peaking at 48 h of exposure to oxLDL (Figure 1D). To ensure
that this is a dynamic and complete autophagic process and not just
the accumulation of endocytosed oxLDL in autophagic vesicles, we
blocked the fusion of the autophagosome with the lysosome using
baﬁlomycin A1. Baﬁlomycin A1 led to a dramatic accumulation of
the unprocessed LC3-II (Figure 1E). This observation provided con-
vincing evidence that oxLDL indeed caused autophagic ﬂux (30).
OxLDLs upregulate POX in cancer cells
To ascertain whether POX is involved in oxLDL-mediated signaling,
we sought oxLDL-dependent effects on POX promoter activity in
cancer cells (Figure 2A). Among the tested cells, OVCAR3, OV-
CAR5, MCF7 and A549 presented modest activation of POX pro-
moter. In these cell lines, POX promoter activity increased up to
4-fold with 200 lg/ml oxLDL relative to nLDL-treated controls.
HT29 and PC3 cells showed strikingly high activity of the POX
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and dose-dependent response of the POX promoter to oxLDL treat-
ment (Figure 2B and C). POX promoter activity increased 2-fold by
6 h and almost up to 15-fold at 24 h relative to nLDL-treated controls.
The dose-dependent response was found to be 1.6-fold with 100, 8.7-
fold with 200 and 10.4 with 300 lg/ml oxLDL, respectively (Figure
2C). Native LDL did not cause signiﬁcant POX promoter activation
relativeto untreated controls. OxLDL concentrations ,100 lg/ml had
no effect on POX promoter activity in HT29 (data not shown).
To solidify the aforementioned ﬁnding, we further assessed
oxLDL-dependent POX gene expression by determining POX mes-
senger RNA (mRNA) with RT–PCR. POX gene expression increased
3.5-fold in HT29 (Figure 2Da, S. 1A) and 10-fold in PC3 (Figure 2Db,
S. 1B) at 12 h with 200 lg/ml of oxLDL. Native LDL did not affect
POX mRNA levels. Consistently, POX protein levels on western im-
munoblots increased in a dose-dependent fashion in HT29treated with
oxLDL, whereas it decreased in nLDL-treated cells (Figure 2E). We
also found a consistent dose-dependent increase in POX enzymatic
activity in the cells treated with oxidized lipoproteins (Figure 2F). In
this experiment, native LDL had a slight effect on POX activity at
higher concentrations, presumably due to partial oxidation of LDL
during in vitro experiments.
Oxidized LDL activate POX gene expression in HUVEC
Endothelial cells are commonly studied as targets of oxLDL because
they are most frequently exposed to oxLDL in the human organism.
Thus, we used HUVEC to examine the effect of oxLDL on cellular
viability and POX expression in normal untransformed cells. Testing
the effect of lipoproteins on HUVEC viability, we found that oxLDL
has a dose-dependent cytotoxic effect comparedwithnLDL (Figure 1A
and B). This drastic effect on viability was preceded by the increase
of POX mRNA levels in a dose-dependent manner in the cells treated
with oxLDL for 6 h (Figure 2G). There is a stable trend of increasing
POX gene expression starting at a concentration of oxLDL as low
as 25 lg/ml, reaching almost 5-fold at 200 lg/ml compared with
untreated control; nLDL had no signiﬁcant effect.
7-ketocholesterol, the majorcomponent of oxLDL, has a similareffect
on POX in cancer cells
We asked whether the intact oxLDL particle was uniquely necessary
for its molecular signaling (31) or whether one of its chemical
components could substitute for oxLDL. We tested several
oxLDL constituents, including hydroxynonenal, hydroperoxynone-
nal, 3-chlorothyrosine, 15-hydroxyeicosatetraenoic acid (15-HETE),
and none had a signiﬁcant effect on POX promoter activity (data not
shown). Surprisingly, we found that 7-ketocholesterol (7KC), a major
oxysterol of oxLDL, uniquely activated POX in a manner similar to
oxLDL. 7KC at 2.5 and 25 lM signiﬁcantly increased POX promoter
activity in both HT29 and PC3 cells (Figure 3A). Consistently, 7KC
also increased POX gene expression in a dose-dependent manner in
HT29 (Figure 3B).
OxLDL and 7KC activate POX through PPARc
Since both HT29 and PC3 showed robust responses of POX promoter
activity to oxLDL, and both have wild type PPARc (17,32), we won-
dered whether the effect of oxLDL on POX is mediated by this nu-
clear receptor. To test this, we knocked down PPARc (data not shown)
and measured POX promoter activity in the cells treated with lip-
oproteins. PPARc knockdown signiﬁcantly decreased the response
of POX promoter to oxLDL in both HT29 and PC3 (Figure 3C and
D, respectively). The same effect was found at the level of gene
expression in HT29 (Figure 3E). Additionally, we found that PPARc
knockdown decreased 7KC-mediated POX promoter activation in
HT29 almost to the level of untreated control (Figure 3F).
Fig. 1. Cytotoxic effect of oxLDL. (A) The effect of oxLDL and (B) nLDL on viability measured in various cancer cells and HUVEC treated for 24 h with
lipoproteins as speciﬁed. (C) Phase-contrast microscopy picture shows morphology of HT29 cells treated with oxLDL versus nLDL. White arrow shows rounded-
up cells. (D) Western immunoblotting was done for apoptotic and autophagic markers in HT29 cells treated with 200 lg/ml oxLDL for the indicated time. Plus
sign represents positive control; ‘clPARP’ designates cleaved PARP. (E) HT29 cells were treated with either baﬁlomycin A1 (BafA) or dimethyl sulfoxide
(DMSO) as a solvent control simultaneously with 200 lg/ml oxLDL for 24 h. Western immunoblotting for LC3-I and II was done to conﬁrm oxLDL-dependent
autophagic ﬂux. (A and B) Data presented as mean ± SD. (D and E) b-Actin serves as loading control.
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exposed to oxLDL
In an effort to decipher the exact function of POX in oxLDL-
mediated cytotoxicity, we established small interfering RNA-based
POX knockdown (data not shown). After transfection, cells were
treated with 200 lg/ml oxLDL for 24 h. First, we checked whether
POX knockdown may affect cellular viability of cancer cells trea-
ted with oxLDL and found that POX knockdown moderately but
signiﬁcantly decreased cellular viability, suggesting that POX pro-
vided protection against oxLDL-mediated cytotoxicity under these
conditions (Figure 4A).
Since we found that oxLDL activated apoptosis and autophagy in
cancer cells, we wondered whether any of these cellular responses
could be affected by POX knockdown. We found no effect on
PARP cleavage. Instead, we discovered a dramatic decrease in the
autophagy-related conversion of LC3-I to LC3-II as a result of POX
knockdown (Figure 4B). Scramble RNA alone had no effect (data not
shown). Therefore, based on these ﬁndings we conclude that POX is
Fig. 2. OxLDL upregulate POX in cancer and normal cells. (A) POX promoter activity was measured invarious cancer cell lines as indicated after 18 h incubation
with 200 lg/ml oxLDL. The graph represents fold change in relative luciferase activity of oxLDL-treated cells over the nLDL-treated cells. Untreated controls
were run in parallel. NLDL-treated samples showed no POX promoter activation as compared with the untreated samples. (B and C) The graphs represent a fold
changein relative luciferaseactivityin the oxLDL-ornLDL-treatedcells over the untreatedcontrol.(B) Time-and (C) dose-dependenteffectof 200lg/mloxLDL
on POX promoter activity in HT29 cells. In (C), cells were treated for 18 h. (D) RT–PCR analysisof POX mRNA from (a) HT29 and (b) PC3 cells treated with200
lg/ml oxLDL for the time speciﬁed. The samples were run in duplicates. (E) Western immunoblot analysis of POX protein levels in HT29 cells treated with
oxLDL or nLDL as speciﬁed. (F) The graph shows POX enzymatic activity, expressed as amount of generated pyrroline-5-carboxylate (P5C) in nanomolar per
minute per microgram protein under the inﬂuence of lipoproteins, representing dose-dependent effect. (G) The effect of oxLDL on POX expression in HUVEC
was estimated with quantitative PCR. The cells were treated for 6 h with various concentrations of lipoproteins. Data are shown as relative POX mRNA level
normalized to b-actin in oxLDL/nLDL-treated samples over untreated controls. (A–C, F and G) All data presented as a mean ± SD,  P   0.05,   P   0.01.
(D and E) b-Actin serves as loading control.
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exposed to oxLDL.
POX regulates autophagy through beclin-1
A recent report suggests that oxLDL may regulate cellular fate
through mTOR (33), an important player in cellular energy homeo-
stasis and a major regulator of autophagy (34). However, it was
determined that POX responds to metabolic stress downstream of
mTOR (23). Therefore, we asked whether POX, in turn, may regulate
oxLDL-dependent autophagy indirectly through mTOR. The marked
decrease in both total and phosphorylated mTOR with oxLDL treat-
ment and the inability of POX knockdown to mitigate this oxLDL
effect led us to exclude mTOR involvement in oxLDL/POX-
dependent regulation of autophagy (data not shown).
To address the question of how autophagy is regulated in this sit-
uation, we also examined the effect of POX knockdown on beclin-1,
which is one of the central regulators of autophagy in mammalian
cells (35,36). First, we found that oxLDL increased beclin-1 gene
expression at the mRNA level (data not shown), but did not change
the amount of beclin-1 protein. The latter may be explained by the
rapid protein turnover in the cell undergoing active autophagy. The
important fact that POX knockdown was able to decrease beclin-1
protein level (Figure 4B) in cells treated with oxLDL provided evi-
dence that the effect of POX on autophagy is possibly mediated
through beclin-1.
To conﬁrm this ﬁnding we used DLD-1 Tet-off POX cells, which
stably overexpress POX under doxycycline control (18). We found
that POX expression accompanying doxycycline withdrawal triggers
autophagosome accumulation (Figure 4Da), and conversion of LC3-I
into LC3-II (Figure 4Db), as well as increases expression of beclin-1
(Figure 4E, left side). The presence of autophagic ﬂux was conﬁrmed
using baﬁlomycin A1, which led to a striking accumulation of the
unprocessed LC3-II (Figure 4Dc). Therefore, we conclude that not
only did oxLDLs mediate POX upregulation but also POX overex-
pression, by itself, is sufﬁcient to upregulate autophagy.
OxLDL triggers POX-mediated ROS generation in cancer cells
Autophagy is a prosurvival response to metabolic stress (37), the
survival of even a few cancer cells enables tumor regrowth. Thus,
the mechanism by which POX mediates the demonstrated regulation
is of considerable interest. There are two major pathways for POX-
dependent regulation. Metabolizing proline, POX can generate ATP
or ROS (38). To distinguish between these possibilities, we ﬁrst mea-
sured ATP levels in oxLDL-treated cells. A decrease in ATP would ﬁt
Fig. 3. The effect of 7KC on POX and the role of PPARc.( A) POX promoter activity was estimated in cancer cells after the treatment with 7KC at speciﬁed
concentrations for 18 h.Thegraphdepicts foldincreasein relativeluciferaseactivity in oxLDL-treated cells overnLDL-treatedcells.7KC solvent ethanolcontrols
were run in parallel. NLDL-treated samples showed no POX promoter activation as compared with the solvent controls. (B) Quantitative PCR results plotted
as relative POX mRNA levels normalized to b-actin mRNA from HT29 cells treated with increasing concentrations of 7KC for 24 h. (C–F) The cells were either
transfected with PPARc small interfering RNA (KD) or scrambled RNA (scr) (data not shown). Both samples were treated with oxLDL or 7KC as indicated. Each
experimenthadintactuntreatedwild-type(WT)asreference.(C) POXpromoter activityin HT29and (D) PC3cancer cells treatedwith200lg/mloxLDLfor18h.
(E) Quantitative PCR was done to estimate the level of POX mRNA in HT29 treated with 200 lg/ml oxLDL for 12 h. (F) POX promoter activity in HT29 treated
with 25 lM 7KC for 18 h. (A–F) All data presented as mean ± SD,  P , 0.05,   P , 0.01.
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in a decreased viability. However, we found no effect on ATP levels
with POX knockdown in this setting (data not shown). It is notewor-
thy, nevertheless, that oxLDL did decrease intracellular ATPalmost 2-
fold compared with nLDL or an untreated control. Several studies
reported that oxLDL and its components impair cell energy metabo-
lism by downregulating variety of metabolic enzymes (39–41), which
may be the explanation as towhy ATP was unaffected by POX knock-
down. Further, we examined the alternative mechanistic possibility of
POX-dependent ROS generation. Remarkably, we found that oxLDL
markedly increased intracellular ROS generation (254.9%) and, more
importantly, nearly two-thirds of the oxLDL-stimulated ROS was
POX dependent (Figure 4C).
POX-generated superoxide is essential for beclin-1 upregulation
Having shown that POX is activated by oxLDL through PPARc, and
POX initiates autophagy through the induction of beclin-1, the mech-
anism for the POX-mediated effect becomes critically important. We
found that POX regulates autophagy and hypothesized that this occurs
via POX-dependent ROS generation. To conﬁrm this we aimed to
establish a direct link between POX enzymatic activity and beclin-1
expression. In DLD-1 Tet-off POX cells the expression of POX trig-
gered beclin-1 upregulation (Figure 4E, left side). That this was de-
pendent on POX catalytic activity, but not due to accumulation of the
excess of protein, was shown using dehydroproline, a competitive
inhibitor of POX. Inhibition of POX activity in the face of POX
overexpression consistently and markedly mitigated the increase in
beclin-1 expression accompanying the withdrawal of doxycycline
(Figure 4E, right side). POX mRNA levels were measured in the same
samples to ensure the overexpression ofPOX (data notshown). There-
fore, we conclude that POX catalytic activity is required to upregulate
beclin-1. Sincewe found that oxLDL-dependent regulation of autoph-
agy depends on POX-generated ROS, we aimed to test whether it
is speciﬁc for POX-generated superoxide (20). We infected DLD-1
Fig. 4. Role of POX in oxLDL-mediated cytotoxicity. For (A–C), cells were transfected with either POX RNA interference (KD) or scrambled RNA (scr)
(data not shown). Both samples were treated with 200 lg/ml oxLDL for 24 h. Untreated intact and/or nLDL-treated sample were run as control in each
experiment. (A) Cellular viability was measured with MTS in HT29. (B) Western immunoblotting for apoptotic and autophagic markers. ‘clPARP’designates
cleaved PARP. (C) Relative ROS were measured as ﬂuorescence intensity and expressed relative to total protein amount in the sample. (D)( a)C o n f o c a l
microscopy image of the DLD-1 Tet-off POX cells with and without doxycycline. Autophagosomes accumulation is tracked by the transient transfection of
mCherry-LC3 vector (red ﬂuorescence). (b) Western immunoblotting for autophagic LC3-I and II in DLD-1 Tet-off POX cells with and without doxycycline.
(c) Western immunoblotting showing the presence of the autophagic ﬂux in the DLD-1 Tet-off POX cells withdrawn from doxycycline, which were treated
with either baﬁlomycin A1 (BafA) or DMSO (solvent control). (E) Quantitative PCR data presenting relative beclin-1 mRNA expression in DLD Tet-off POX
cells with and without doxycycline, as well as with and without inhibitor of POX catalytic activity dehydroproline (DHP). (F) Quantitative PCR data
presenting relative beclin-1 mRNA expression in DLD-1 Tet-off POX cells with and without doxycycline, as well as infected either with an empty control
virus (Ad-Empty) or with an adenoviral MnSOD (Ad-MnSOD). (A, C, E and F) Data presented as mean ± SD,  P   0.05,   P   0.01. (B and D) b-Actin
represents loading control.
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shown), which is responsible for POX-dependent superoxide detoxi-
ﬁcation (20), and found that it was able to reduce beclin-1 expression
under docycycline withdrawal similar to dehydroproline (Figure 4F).
These results conﬁrm our hypothesis that POX regulates autophagy by
superoxide-dependent induction of beclin-1.
Discussion
A number of reports have described the dichomatous properties of
oxLDL. Our studies clearly show that oxLDLs have cytotoxic effects
concurrently activating both apoptosis and autophagy in cancer cells.
We establish here for the ﬁrst time a link between metabolism of
blood-borne lipids and amino acids. Speciﬁcally, we show that oxi-
dized cholesterol-bearing lipoproteins applied in physiological con-
centrations (28,29) upregulate a key enzyme of proline metabolism,
POX, in cancer cells and normal HUVECs. In contrast, native nLDL
had no effect on POX promoter activity and mRNA levels, suggesting
that oxidized components play a pivotal role in POX regulation.
NLDL was able to decrease POX protein levels because they serve
as a major energysource and may competewith proline, an alternative
energy source. This is consistent with a previous report that POX
activity was inhibited by long-chain acyl coenzyme A generated pre-
sumably during lipolysis (42). These ﬁndings once again emphasize
pathophysiologic alterations of lipid and amino acid metabolism in
both atherosclerosis and cancer. We show here for the ﬁrst time that
those alterations may be a direct result of oxLDL toxicity.
LDL is a complex nanoparticle with a cholesterol ether core envel-
oped by phospholipids, non-esteriﬁed cholesterol and apolipoprotein
B100. Subjected to oxidative stress, each and all LDL components
may be oxidized (43). It was not known whether it is the complex
structure (31) of the oxLDL particle in toto or its speciﬁc components
that are responsible for its interaction with molecular targets. To
identify a component of oxLDL responsible for POX activation, we
tested several constituents of oxLDL and found that only 7KC acti-
vates in a manner similar to total oxLDL. 7KC is present in human
atherosclerotic plaques and plays an active role in plaque develop-
ment through the induction of apoptosis in vascular endothelial cells
(44). Oxysterols are elevated in human LDL and their higher plasma
levels is associated with an increased risk of atherosclerosis (43). In
regard to cancer, oxysterols had a cytotoxic effect on human neuro-
blastoma cells (45). This fact is consistent with our observation that
oxLDL, bearing 7KC, is cytotoxic to cancer cells.
The presence of PPARc ligands in oxLDL (16) and the robust POX
response to PPARc signaling (17,46) strongly suggested that the
oxLDL effects on POX involve PPARc. Our knockdown experiments
showed that oxLDL indeed regulate POX through the PPARc nuclear
receptor in both HT29 and PC3. For the 7KC effect on POX, however,
the dependence on PPARc is evident in HT29, but not in PC3. The
knockdown of PPARc in HT29 colon cancer cells completely abol-
ished the 7KC-dependent increase in POX, but did not block the 7KC
effect on POX in PC3 cells (data not shown). We can only speculate
that the effect of 7KC on POX in PC3 prostate cancer cells may
involve additional signaling pathways.
Althoughourlaboratorypreviouslydescribedmainlyaproapoptotic
function of POX (21), POX knockdown did not affect oxLDL-
dependent apoptosis. This may be due to the complex structure of
oxLDL and synergistic or overlapping effects of various oxLDL com-
ponents, including PPARc-mediated signaling in addition to POX.
Instead, POX knockdown interfered with the autophagic pathway.
Whether oxidized lipids use POX as a switch for autophagy is an
attractive possibility. Clearly, POX plays a role in regulating autoph-
agy in cancer cells. The fact that decreased cellular viability in
oxLDL-treated cells was further accentuated by POX knockdown
emphasizes the prosurvival role of POX upregulation. Together with
the ﬁnding that POX knockdown interfered with autophagy activation
led us to conclude that POX activates protective autophagy and serves
as a survival response to the cytotoxic effect of oxLDL. This ﬁnding
becomes even more intriguing because the POX metabolic system
was recently deﬁned as part of the ‘ecophagy’ machinery. Ecophagy
literally means ‘eating its environment’ and was proposed as a mech-
anism (38) among others, such as autophagy (26) and entosis (47) for
survival of cancer cells. The temporal sequence of these processes in
the tumor microenvironment remains unclear, but our current work
shows that activation of the central player of ecophagy, POX, may
precede and activate autophagy. As we mentioned previously, this
sequence may be advantageous forthe cancer cell inthat ithas a‘spar-
ing’ effect (48). Moreover, oxLDL-related carcinogenic effects may
arise when oxLDL damage the cells; repair mechanism and POX-
dependent autophagy are activated, which altogether may allow se-
lection of cancer stem cells (49). Although POX was initially found to
be involved in the apoptotic process downstream of p53 (50), HT29
has mutant and PC3 has null p53; therefore, all POX-dependent reg-
ulation of autophagy described here is p53 independent.
POX is a multifunctional enzyme and its structure underlines its
multiple functions (51). The pair of electrons transferred from proline
to the ﬂavine adenine dinucleotide of POX may be donated to the
electron transport chain to generate ATP (23). Alternatively, electrons
may directly reduce solvent oxygen to produce superoxide and its
derivatives (18,51). These POX-dependent products may also serve
as direct signaling molecules. Strikingly, we found that nearly
two-thirds of oxLDL-mediated ROS generation is POX dependent.
Therefore, POX knockdown decreased autophagy and simulta-
neously decreased POX-dependent ROS generation. Using a POX-
overexpressing cell model, DLD-1 Tet-off POX, we found that
beclin-1 gene expression is directly dependent on POX catalytic ac-
tivity and POX-dependent superoxide. Superoxide is a speciﬁc ROS
generated by POX (20). Recently, autophagy was found to be regu-
lated by mitochondrial superoxide (52), but to our knowledge, this is
the ﬁrst report of a speciﬁc metabolic enzyme responsible for this
regulation. Thus, we describe here for the ﬁrst time that POX, acting
as a stress response mechanism, regulates protective autophagy in
cancer cells by generating ROS.
To summarize, we have established that oxLDL can initiate cell
death in cancer cells. The key metabolic enzyme of proline degrada-
tion, POX, is regulated by oxLDL and it plays a regulatory role in
oxLDL-mediated prosurvival autophagy. This mechanism is based on
one of the chemical components of oxLDL, 7KC, through PPARc.W e
also showed that the POX effect on autophagic machinery is executed
through the generation of superoxide and subsequent regulation of
beclin-1 (Figure 5).
Fig. 5. Dual role of oxLDL in cancer cells. OxLDL activate both apoptosis
and autophagy in cancer cells. While apoptosis deﬁnitely leads to cellular
death, autophagy is activated as a prosurvival mechanism. Autophagy,
speciﬁcally beclin-1 transcription, is being regulated by POX-dependent
superoxide through oxLDL-derived 7KC involving PPARc. This mechanism
provides sustained cellular survival under the conditions of oxLDL-mediated
stress.
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